|
Research
Mercy NeuroScience Institute leads the state in the latest MS research
and clinical trials.
Quality of life
The MS Center is participating in a national study to determine how
likely patients are continue with treatment if injecting their
medication is required.
Minimizing side effects
Tests are currently underway to study medications that could reduce
potential reactions to MS drug therapy.
Combination therapy
As with many medical conditions, using more than one medication can
improve disease control. Research is evaluating the effect of combining
an immunomodulator with one or two immunosupressants.
Medication comparison
A team of researchers is evaluating immunomodulators on the market to
determine the advantages of each one.
<
1 2
3 4
5 >
|